Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dimensional US Small Cap ETF
DFAS
|
+$269M |
| 2 |
FlexShares Global Upstream Natural Resources Index Fund
GUNR
|
+$196M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$176M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$163M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$139M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$1.75B |
| 2 |
Apple
AAPL
|
+$727M |
| 3 |
CSX Corp
CSX
|
+$394M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$353M |
| 5 |
Microsoft
MSFT
|
+$300M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.36% |
| 2 | Financials | 12.84% |
| 3 | Healthcare | 12.33% |
| 4 | Consumer Discretionary | 11.5% |
| 5 | Communication Services | 9.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
Kinross Gold
KGC
$31.9B
| $6.67M | ﹤0.01% |
1,050,376
-183,032
| -15% | -$1.36M |
|
|
CFB
2652
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $6.66M | ﹤0.01% |
484,047
-12,197
| -2% | -$176K |
|
|
PTVE
2653
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $6.65M | ﹤0.01% |
441,404
+5,858
| +1% | +$87.9K |
|
2654
Rush Street Interactive
RSI
$2.85B
| $6.64M | ﹤0.01% |
541,923
+455,543
| +527% | +$6.12M |
|
2655
Stoke Therapeutics
STOK
$2.02B
| $6.64M | ﹤0.01% |
197,252
+10,592
| +6% | +$374K |
|
|
ESPR
2656
DELISTED
Esperion Therapeutics
ESPR
| $6.62M | ﹤0.01% |
312,888
+7,963
| +3% | +$192K |
|
2657
Annexon
ANNX
$862M
| $6.62M | ﹤0.01% |
293,908
+36,548
| +14% | +$810K |
|
2658
Liberty Latin America Class A
LILA
$1.67B
| $6.61M | ﹤0.01% |
701,794
-38,616
| -5% | -$366K |
|
2659
Phathom Pharmaceuticals
PHAT
$743M
| $6.6M | ﹤0.01% |
194,876
+63,020
| +48% | +$2.26M |
|
2660
Outdoor Holding Co
POWW
$255M
| $6.59M | ﹤0.01% |
673,065
+570,287
| +555% | +$4.05M |
|
|
CNR
2661
Core Natural Resources Inc
CNR
$4.64B
| $6.59M | ﹤0.01% |
356,642
+27,080
| +8% | +$364K |
|
2662
Precision BioSciences
DTIL
$201M
| $6.58M | ﹤0.01% |
17,527
+1,021
| +6% | +$307K |
|
2663
Keros Therapeutics
KROS
$211M
| $6.58M | ﹤0.01% |
154,938
+27,068
| +21% | +$1.47M |
|
2664
Ardelyx
ARDX
$1.01B
| $6.56M | ﹤0.01% |
865,276
+40,423
| +5% | +$299K |
|
|
EGRX
2665
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $6.55M | ﹤0.01% |
153,164
+19,001
| +14% | +$784K |
|
2666
Forrester Research
FORR
$224M
| $6.55M | ﹤0.01% |
143,119
-4,338
| -3% | -$187K |
|
2667
Roblox
RBLX
$27.1B
| $6.55M | ﹤0.01% |
72,819
+18,426
| +34% | +$1.48M |
|
2668
Precigen
PGEN
$2.32B
| $6.55M | ﹤0.01% |
1,004,668
+167,861
| +20% | +$1.17M |
|
2669
VistaGen Therapeutics
VTGN
$11.8M
| $6.55M | ﹤0.01% |
69,306
+60,541
| +691% | +$4.49M |
|
|
NBP
2670
NovaBridge Biosciences American Depositary Shares
NBP
$220M
| $6.55M | ﹤0.01% |
+78,007
| New | +$5.15M |
|
|
TBRG
2671
DELISTED
TruBridge
TBRG
| $6.54M | ﹤0.01% |
196,661
+8,048
| +4% | +$255K |
|
2672
Turning Point Brands
TPB
$1.73B
| $6.53M | ﹤0.01% |
142,718
+13,893
| +11% | +$642K |
|
|
BRY
2673
DELISTED
Berry Corp
BRY
| $6.53M | ﹤0.01% |
971,744
-15,554
| -2% | -$98.4K |
|
2674
Republic Bancorp
RBCAA
$1.92B
| $6.53M | ﹤0.01% |
141,501
-5,640
| -4% | -$258K |
|
2675
Driven Brands
DRVN
$2.12B
| $6.5M | ﹤0.01% |
210,174
+26,439
| +14% | +$745K |
|
Similar funds
Northern Trust's Q2 2021 Portfolio in Review
As of Q2 2021, Northern Trust held 4,700 positions worth $568B, up 5.6% from $538B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Northern Trust's Q2 2021 filing shows 228 new, 1,693 increased, 2,389 reduced and 115 closed positions. Its largest new stake was Dimensional US Small Cap ETF: 4,630,698 shares worth $2.71M. The largest sale was Alibaba, an estimated $1.75B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- Northern Trust's largest Q2 2021 buy was Dimensional US Small Cap ETF: 4,630,698 shares worth $2.71M.
- Northern Trust added most to FlexShares Global Upstream Natural Resources Index Fund in Q2 2021, an estimated $196M increase.
- Northern Trust's biggest Q2 2021 reduction was Alibaba, cutting an estimated $1.75B.
- Northern Trust fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $203M.
- Northern Trust's ten largest holdings make up 21% of its $568B portfolio in Q2 2021.
- Northern Trust opened 228 new positions and closed 115 in Q2 2021.
- Northern Trust's portfolio value rose 5.6% quarter-over-quarter to $568B.
Based on Northern Trust's 13F filing for Q2 2021, filed 13 Aug 2021.